Preliminary Study of Urinary Excretion of Liver-type Fatty Acid-binding Protein in a Cat Model of Chronic Kidney Disease

Overview

Journal Can J Vet Res

Specialty Veterinary Medicine

Date 2021 Apr 22

PMID 33883825

Citations 1

Authors

Akiko Watanabe

Keiichi Ohata

Tsuyoshi Oikawa

Takeshi Sugaya

Masao Miyazaki

Hiroshi Satoh

Masaaki Katayama

Affiliations

Soon will be listed here.

Abstract

Urinary liver-type fatty acid-binding protein (uL-FABP) is a clinically useful biomarker for monitoring chronic kidney disease (CKD) in humans. However, long-term monitoring of uL-FABP in CKD cats has not been reported. The objective of this preliminary study was to investigate whether the urinary excretion of L-FABP could predict the deterioration of renal function in 2 CKD model cats. Urinary liver-type fatty acid-binding protein (uL-FABP) increased before standard renal biomarkers, including serum creatinine, blood urea nitrogen, and symmetric dimethylarginine, in 1 cat with deteriorating renal function, but remained low and relatively stable in another cat with stable renal function. Our results suggest that uL-FABP is a potential clinical biomarker for predicting the progression of CKD in cats, as it is in humans.

Citing Articles

Reduction of urinary felinine in domestic cats with renal diseases leads to decreased catty odor.

Suka A, Uenoyama R, Ichizawa S, Katayama M, Miyazaki M, Miyazaki T J Vet Med Sci. 2024; 87(1):61-67.

PMID: 39631957 PMC: 11735215. DOI: 10.1292/jvms.24-0370.

Clinical evaluation of urinary liver-type fatty acid-binding protein for the diagnosis of renal diseases in dogs.

Takashima S, Nagamori Y, Ohata K, Oikawa T, Sugaya T, Kobatake Y J Vet Med Sci. 2021; 83(9):1465-1471.

PMID: 34526412 PMC: 8498833. DOI: 10.1292/jvms.20-0698.

References

Hisamichi M, Kamijo-Ikemori A, Sugaya T, Ichikawa D, Hoshino S, Hirata K . Increase in urinary markers during the acute phase reflects the degree of chronic tubulointerstitial injury after ischemia-reperfusion renal injury. Biomarkers. 2016; 22(1):5-13. DOI: 10.3109/1354750X.2016.1153723. View

Marino C, Lascelles B, Vaden S, Gruen M, Marks S . Prevalence and classification of chronic kidney disease in cats randomly selected from four age groups and in cats recruited for degenerative joint disease studies. J Feline Med Surg. 2013; 16(6):465-72. PMC: 4414065. DOI: 10.1177/1098612X13511446. View

Kamijo A, Sugaya T, Hikawa A, Yamanouchi M, Hirata Y, Ishimitsu T . Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem. 2006; 284(1-2):175-82. DOI: 10.1007/s11010-005-9047-9. View

Bartlett P, Van Buren J, Neterer M, Zhou C . Disease surveillance and referral bias in the veterinary medical database. Prev Vet Med. 2010; 94(3-4):264-71. DOI: 10.1016/j.prevetmed.2010.01.007. View

Polzin D . Evidence-based step-wise approach to managing chronic kidney disease in dogs and cats. J Vet Emerg Crit Care (San Antonio). 2013; 23(2):205-15. DOI: 10.1111/vec.12034. View

Lawson J, Syme H, Wheeler-Jones C, Elliott J . Urinary active transforming growth factor β in feline chronic kidney disease. Vet J. 2016; 214:1-6. PMC: 4949776. DOI: 10.1016/j.tvjl.2016.02.004. View

Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hikawa A, Hirano N . Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med. 2004; 143(1):23-30. DOI: 10.1016/j.lab.2003.08.001. View

Fujita D, Takahashi M, Doi K, Abe M, Tazaki J, Kiyosue A . Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease. Heart Vessels. 2014; 30(3):296-303. DOI: 10.1007/s00380-014-0484-9. View

Katayama M, Ohata K, Miyazaki T, Katayama R, Wakamatsu N, Ohno M . Renal expression and urinary excretion of liver-type fatty acid-binding protein in cats with renal disease. J Vet Intern Med. 2020; 34(2):761-769. PMC: 7096645. DOI: 10.1111/jvim.15721. View

10.

Klahr S, Morrissey J . Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol. 2002; 283(5):F861-75. DOI: 10.1152/ajprenal.00362.2001. View

11.

Vaughan Jr E, GILLENWATER J . Recovery following complete chronic unilateral ureteral occlusion: functional, radiographic and pathologic alterations. J Urol. 1971; 106(1):27-35. DOI: 10.1016/s0022-5347(17)61219-9. View

12.

Berent A, Weisse C, Bagley D, Lamb K . Use of a subcutaneous ureteral bypass device for treatment of benign ureteral obstruction in cats: 174 ureters in 134 cats (2009-2015). J Am Vet Med Assoc. 2018; 253(10):1309-1327. DOI: 10.2460/javma.253.10.1309. View

13.

Narvaez Barros A, Guiteras R, Sola A, Manonelles A, Morote J, Cruzado J . Reversal Unilateral Ureteral Obstruction: A Mice Experimental Model. Nephron. 2019; 142(2):125-134. DOI: 10.1159/000497119. View

14.

Tapmeier T, Brown K, Tang Z, Sacks S, Sheerin N, Wong W . Reimplantation of the ureter after unilateral ureteral obstruction provides a model that allows functional evaluation. Kidney Int. 2008; 73(7):885-9. DOI: 10.1038/sj.ki.5002797. View

15.

Kamijo-Ikemori A, Sugaya T, Obama A, Hiroi J, Miura H, Watanabe M . Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction. Am J Pathol. 2006; 169(4):1107-17. PMC: 1780178. DOI: 10.2353/ajpath.2006.060131. View

16.

Berent A, Weisse C, Todd K, Bagley D . Technical and clinical outcomes of ureteral stenting in cats with benign ureteral obstruction: 69 cases (2006-2010). J Am Vet Med Assoc. 2014; 244(5):559-76. DOI: 10.2460/javma.244.5.559. View

17.

Brown C, Rissi D, Dickerson V, Davis A, Brown S, Schmiedt C . Chronic Renal Changes After a Single Ischemic Event in an Experimental Model of Feline Chronic Kidney Disease. Vet Pathol. 2019; 56(4):536-543. DOI: 10.1177/0300985819837721. View

18.

Chevalier R, Forbes M, Thornhill B . Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 2009; 75(11):1145-1152. DOI: 10.1038/ki.2009.86. View

19.

Delanghe J, Speeckaert M . Creatinine determination according to Jaffe-what does it stand for?. NDT Plus. 2015; 4(2):83-6. PMC: 4421578. DOI: 10.1093/ndtplus/sfq211. View

20.

Katayama M, Miyazaki T, Ohata K, Oikawa T, Kamiie J, Sugaya T . Temporal changes in urinary excretion of liver-type fatty acid binding protein (L-FABP) in acute kidney injury model of domestic cats: a preliminary study. J Vet Med Sci. 2019; 81(12):1868-1872. PMC: 6943323. DOI: 10.1292/jvms.19-0325. View